Dr. Dimopoulos - Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study
Meletios A. Dimopoulos, MD
Greek Myeloma Study Group
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.